Search research articles
Contact Us
Filters
Showing results (41-50 of 70) with videos related to
Page
of 7
Sort By:
European Journal of Nuclear Medicine
|
January 1, 1991
Benzodiazepine receptors and cerebral blood flow in partial epilepsy
P Bartenstein, A Ludolph, O Schober, et al.
European Journal of Nuclear Medicine
|
June 1, 1996
Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability
K Scheidhauer, A Scharl, U Pietrzyk, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|
March 11, 2016
[Retrorectal space-occupying lesion: a rare differential diagnosis]
M Sohn, I Iesalnieks, H Rohrbach, et al.
Nuclear Medicine Communications
|
February 24, 2001
Follow-up of differentiated thyroid cancer: comparison of multiple diagnostic tests
M Dietlein, D Moka, K Scheidhauer, et al.
European Radiology
|
July 2, 2003
Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions
C Walter, K Scheidhauer, A Scharl, et al.
Nuklearmedizin. Nuclear Medicine
|
October 1, 1996
[Relationship between properties of 131I therapy and radioiodine kinetics]
K Schomäcker, U Wellner, K Scheidhauer, et al.
HNO
|
January 7, 1998
[99mTc-MDP-SPECT for detection of subclinical mandibular infiltration of squamous epithelial carcinoma]
M Jungehülsing, K Scheidhauer, N Litzka, et al.
Nuclear Medicine Communications
|
March 27, 1999
Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis
M Dietlein, B Krug, W Groth, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
October 4, 2000
Fluor-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant melanoma. Diagnostic comparison with conventional imaging methods
B Krug, M Dietlein, W Groth, et al.
Nuklearmedizin. Nuclear Medicine
|
April 1, 1993
[Long term biokinetics of 169Yb following injection as citrate, hydroxyethylethylenediaminetetraacetate and nitrilotriacetate]
K Schomäcker, K Scheidhauer, W G Franke, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 70) with videos related to
Sort By:
Page
of 7
European Journal of Nuclear Medicine
|
January 1, 1991
Benzodiazepine receptors and cerebral blood flow in partial epilepsy
P Bartenstein, A Ludolph, O Schober, et al.
European Journal of Nuclear Medicine
|
June 1, 1996
Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability
K Scheidhauer, A Scharl, U Pietrzyk, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|
March 11, 2016
[Retrorectal space-occupying lesion: a rare differential diagnosis]
M Sohn, I Iesalnieks, H Rohrbach, et al.
Nuclear Medicine Communications
|
February 24, 2001
Follow-up of differentiated thyroid cancer: comparison of multiple diagnostic tests
M Dietlein, D Moka, K Scheidhauer, et al.
European Radiology
|
July 2, 2003
Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions
C Walter, K Scheidhauer, A Scharl, et al.
Nuklearmedizin. Nuclear Medicine
|
October 1, 1996
[Relationship between properties of 131I therapy and radioiodine kinetics]
K Schomäcker, U Wellner, K Scheidhauer, et al.
HNO
|
January 7, 1998
[99mTc-MDP-SPECT for detection of subclinical mandibular infiltration of squamous epithelial carcinoma]
M Jungehülsing, K Scheidhauer, N Litzka, et al.
Nuclear Medicine Communications
|
March 27, 1999
Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis
M Dietlein, B Krug, W Groth, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
October 4, 2000
Fluor-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant melanoma. Diagnostic comparison with conventional imaging methods
B Krug, M Dietlein, W Groth, et al.
Nuklearmedizin. Nuclear Medicine
|
April 1, 1993
[Long term biokinetics of 169Yb following injection as citrate, hydroxyethylethylenediaminetetraacetate and nitrilotriacetate]
K Schomäcker, K Scheidhauer, W G Franke, et al.
Page
of 7